Stay updated on Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new site-wide banner about government funding status was added and the site version updated to v3.4.1 (from v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:38:54.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Glossary display is now shown; page metadata updated with Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0, while previous QC text Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4 were removed.
    Difference
    0.1%
    Check dated 2026-01-28T04:08:09.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Footer shows Revision: v3.3.4, replacing v3.3.3; no changes to core content, study details, or links. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-14T03:23:57.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The study Locations section has been updated with numerous new sites across multiple countries and some existing sites removed. This affects where patients can enroll and contact investigators.
    Difference
    3%
    Check dated 2025-12-23T21:22:10.000Z thumbnail image
  6. Check
    74 days ago
    Change Detected
    Summary
    Publications section wording was updated to clarify PubMed autofill may not reflect the study, the previous PubMed-generated note was removed, and the revision number at the bottom was updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-25T10:51:22.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page. It previously warned that information might not be up to date and inquiries might not be processed until appropriations were enacted.
    Difference
    0.1%
    Check dated 2025-11-18T06:58:40.000Z thumbnail image

Stay in the know with updates to Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Margetuximab vs Trastuzumab in HER2+ Metastatic Breast Cancer Clinical Trial page.